Analysts are cautiously optimistic about an IPO rebound for biopharma. BioSpace is keeping track of companies that seek to trade on the public markets this year.
Fallout from the resignation of FDA Commissioner Marty Makary continues as several other senior regulators are removed from their posts; pharma’s top paid CEOs make up to 358 times more than their employees; Revolution Medicine’s pancreatic cancer results highlight movement in the deadly disease space; more.
Clinical trial setbacks have limited the near-term opportunities for some of Daiichi Sankyo’s ADCs but the drug developer is betting near-term readouts will catapult it into the top tier of oncology companies in the coming years.
BioSpace analyzed the pay ratio across 10 major pharmaceutical companies to determine which CEOs were paid the most relative to typical employees. J&J, Eli Lilly and Pfizer once again topped the list.
The House approved legislation to make IRS collection proceedings taxpayer friendly, safeguard tax refunds and provide judicial review of tax liability claims.
The American Institute of CPAs expressed support for legislation limiting the reporting of U.S. businesses’ beneficial ownership information to FinCEN.
The Internal Revenue Service agreed not to continue any legal claims or investigations of the president’s past tax returns, adding to a controversial settlement.
The Institute of Management Accountants announced the availability of its new AI in Finance Micro-credential as part of a larger rollout of similar credentials for specialized finance and accounting competencies.
The Uniform Partition of Heirs’ Property Act helps families avoid forced property sales in at least 24 states, according to a study sponsored by JPMorgan Chase.
The AAM is rebranding itself as the Association for Accounting Growth, reflecting the profession’s evolution and association members’ expanding responsibilities.